文献速递血脂与心血管预防冠心病

年轻心肌梗死患者中家族性高胆固醇血症的患病率与治疗情况

Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

YOUNG-MI回顾性队列研究纳入1996例50岁及以下心肌梗死患者,按荷兰血脂临床标准定义可能或确诊家族性高胆固醇血症(FH)。180例(9%)存在FH,其中42.8%心梗前未用他汀;出院时FH患者高强度他汀使用率63.3%,1年随访LDL-C降低44.4%,但82.2%的FH患者LDL-C仍≥70 mg/dl。

要点

  • 年轻心梗患者中约9%存在临床定义的FH。
  • FH患者出院高强度他汀使用率仅63.3%。
  • 1年时82.2%的FH患者LDL-C≥70 mg/dl。

核心结论

  • 年轻心梗患者中临床定义的FH约占1/10,FH患者出院高强度他汀使用不足且1年LDL-C达标率低。

研究设计与样本

  • YOUNG-MI为回顾性队列研究,纳入2000至2016年2个学术中心50岁及以下发生心梗的患者,共1996例,中位年龄45岁,19%为女性,54%为ST段抬高型心梗。
  • 可能或确诊FH按荷兰血脂临床标准定义。

主要发现

  • 180例(9%)为可能或确诊FH,其中42.8%心梗前未用他汀。
  • 出院时FH患者89.4%用他汀,非FH患者89.9%(p=0.82);FH患者63.3%用高强度他汀,非FH患者48.4%(p<0.001)。
  • 1年随访FH患者LDL-C降低44.4%,非FH患者降低34.5%(p=0.006)。
  • 1年时FH患者LDL-C≥70 mg/dl比例为82.2%,非FH患者为64.5%(p<0.001)。

临床怎么用

  • 对年轻心梗患者应评估FH并按荷兰血脂临床标准识别可能或确诊FH。
  • FH患者心梗后应更积极使用高强度他汀等降脂治疗以改善1年LDL-C达标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are limited data on the prevalence and treatment of familial hypercholesterolemia (FH) among U.S. adults who experience a myocardial infarction (MI) at a young age. OBJECTIVES: This study aimed to evaluate the prevalence of clinically defined FH and examine the rates of statin utilization and low-density lipoprotein cholesterol (LDL-C) achieved 1-year post MI. METHODS: The YOUNG-MI registry is a retrospective cohort study that includes patients who experience an MI at or below age 50 years between 2000 and 2016 at 2 academic centers. Probable or definite FH was defined by the Dutch Lipid Clinic criteria. Outcomes included the proportion of patients classified as probable or definite FH, use of lipid-lowering therapy, and LDL-C achieved 1-year post MI. RESULTS: The cohort consisted of 1,996 adults with a median age of 45 years; 19% were women, and 54% had ST-segment elevation MI. Probable/definite FH was present in 180 (9%) of whom 42.8% were not on statins prior to their MI. Of the 1,966 patients surviving until hospital discharge, 89.4% of FH patients and 89.9% of non-FH patients were discharged on statin therapy (p = 0.82). Among FH patients, 63.3% were discharged on high-intensity statin compared with 48.4% for non-FH patients (p < 0.001). At 1-year follow-up, the percent reduction in LDL-C among FH patients was -44.4% compared with -34.5% (p = 0.006) in non-FH patients. The proportion of patients with LDL-C ≥70 mg/dl was higher among FH patients (82.2%) compared with non-FH patients (64.5%; p < 0.001). CONCLUSIONS: Clinically defined FH was present in nearly 1 of 10 patients with MI at a young age. Only two-thirds of FH patients were discharged on high-intensity statin therapy, and the vast majority had elevated LDL-C at 1 year. These findings reinforce the need for more aggressive lipid-lowering therapy in young FH and non-FH patients post-MI.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Singh A, Gupta A, Collins BL, et al. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction. J Am Coll Cardiol. 2019. PMID: 31097165. doi:10.1016/j.jacc.2019.02.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。